683 CAPITAL MANAGEMENT, LLC Iovance Biotherapeutics, Inc. Transaction History

683 CAPITAL MANAGEMENT, LLC portfolio value:

$16.33M
portfolio value

683 CAPITAL MANAGEMENT, LLC quarter portfolio value change:

-13.22%
quarter

Iovance Biotherapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -14.75% -295K shares -5.74M $9.58 1.70M
Q2 2022 share Increase +33.33% 500K shares -2.89M $11.04 2M
Q1 2022 share Increase +108.33% 780K shares 11.23M $16.65 1.5M
Q4 2021 share Decrease -24.20% -229.82K shares -9.67M $19.42 720K
Q3 2021 share Decrease -7.32% -75K shares -3.24M $24.66 949.82K
Q2 2021 share Increase 0.00% 1.02M shares 26.66M $26.02 1.02M
Q1 2021 share Decrease -100.00% -100K shares -4.64M $31.66 0
Q4 2020 share 0.00% 0 shares 1.34M $46.4 100K
Q3 2020 share 0.00% 0 shares 547K $32.92 100K
Q2 2020 share 0.00% 0 shares -248K $27.45 100K
Q1 2020 share Increase 0.00% 100K shares 2.99M $29.94 100K
Q3 2018 share Decrease -100.00% -350K shares -4.48M $11.25 0
Q2 2018 share 0.00% 0 shares -1.43M $12.8 350K
Q1 2018 share Increase +16.67% 50K shares 3.51M $16.9 350K
Q4 2017 share 0.00% 0 shares 75K $8 300K
Q3 2017 share Increase 0.00% 300K shares 2.32M $7.75 300K